| Literature DB >> 32760865 |
E Melinda Mahabee-Gittens1, Ashley L Merianos2, Meredith E Tabangin3, Lara Stone1, Judith S Gordon4, Jane C Khoury3.
Abstract
INTRODUCTION: Although the administration of free Nicotine Replacement Therapy (NRT) is effective in helping smokers quit, the feasibility, acceptability and safety of this practice have not been examined in the emergency setting of the pediatric emergency department (PED) or urgent care (UC). We examined the characteristics of parental smokers who were interested and eligible for free NRT during their child's emergency visit and the uptake, usage, and associated side effects of NRT use.Entities:
Keywords: nicotine dependence; nicotine replacement therapy; tobacco; tobacco-use cessation
Year: 2020 PMID: 32760865 PMCID: PMC7398133 DOI: 10.18332/tpc/119125
Source DB: PubMed Journal: Tob Prev Cessat ISSN: 2459-3087
Parent characteristics overall and by interest in setting a quit date and receiving free NRT
| Mean (SD) | 33.1 (8.2) | 33.6 (8.2) | 31.9 (8.2) | |
| Median (IQR) | 31.0 (27.0–37.0) | 32.0 (28.0–38.0) | 30.0 (26.0–35.5) | |
| Range | 20.0–64.0 | 20.0–64.0 | 20.0–64.0 | |
| Mean (SD) | 5.1 (4.9) | 5.5 (5.0) | 4.2 (4.6) | |
| Median (IQR) | 3.3 (1.1–8.1) | 3.9 (1.3–9.0) | 2.2 (0.7–6.6) | |
| Range | 0–17.8 | 0–17.8 | 0–17.3 | |
| Female | 330 (87.5) | 215 (85.3) | 115 (92.0) | 0.06 |
| Black, non-Hispanic | 198 (52.5) | 136 (54.0) | 62 (49.6) | |
| White, non-Hispanic | 149 (39.5) | 93 (36.9) | 56 (44.8) | |
| Hispanic | 8 (2.1) | 3 (1.2) | 5 (4.0) | |
| Other | 22 (5.8) | 20 (7.9) | 2 (1.6) | |
| 0.65 | ||||
| Public/self-pay | 324 (85.9) | 218 (88.5) | 106 (84.8) | |
| Commercial | ||||
| 0.74 | ||||
| ≤5000 | 144 (38.2) | 98 (38.9) | 46 (36.8) | |
| 5001–15000 | 87 (23.1) | 53 (21.0) | 34 (27.2) | |
| 15001–30000 | 88 (23.3) | 62 (24.6) | 26 (20.8) | |
| 30001–50000 | 40 (10.6) | 28 (11.1) | 12 (9.6) | |
| >50001 US$ | 18 (4.8) | 11 (4.4) | 7 (5.6) | |
| 0.07 | ||||
| Mean (SD) | 2.46 (1.10) | 2.53 (1.10) | 2.33 (1.10) | |
| Median (IQR) | 2.33 (1.67–3.33) | 2.33 (1.67–3.33) | 2.00 (1.33–3.00) | |
| Range | 1.00–5.00 | 1.00–5.00 | 1.00–5.00 | |
| 162/375 (43.2) | 103/250 (41.2) | 59/125 (47.2) | 0.27 | |
| 0.23 | ||||
| Less than HS | 67 (17.8) | 39 (15.5) | 28 (22.4) | |
| Completed HS | 153 (40.6) | 105 (41.7) | 48 (38.4) | |
| Vocational school | 157 (41.6) | 108 (42.9) | 49 (39.2) | |
| Some College and beyond | ||||
| 0.89 | ||||
| Mean (SD) | 11.5 (7.1) | 11.3 (6.6) | 11.8 (7.9) | |
| Median (IQR) | 10.0 (6.0–15.0) | 10.0 (6.0–15.0) | 10.0 (6.0–15.0) | |
| Range | 1.0–40.0 | 1.0–40.0 | 2.0–40.0 | |
| 0.20 | ||||
| 0 | 116 (30.8) | 71 (28.2) | 45 (36.0) | |
| 1 | 78 (20.7) | 51 (20.2) | 27 (21.6) | |
| ≥2 | 183 (48.5) | 130 (51.6) | 53 (42.4) | |
| 0.58 | ||||
| Mean (SD) | 2.17 (1.38) | 2.19 (1.35) | 2.11 (1.44) | |
| Median (IQR) | 2.0 (1.0–3.0) | 2.0 (1.0–3.0) | 2.0 (1.0–3.0) | |
| Range | 0.0–6.0 | 0.0–6.0 | 0.0–6.0 | |
| Mean (SD) | 6.40 (2.59) | 6.98 (2.38) | 5.23 (2.61) | |
| Median (IQR) | 6.0 (5.0–8.0) | 7.0 (6.0–9.0) | 5.0 (4.0–7.0) | |
| Range | 0.0–10.0 | 0.0–10.0 | 0.0–10.0 | |
| 246 (65.3) | 178 (70.6) | 68 (54.4) |
NRT: nicotine replacement therapy. SD: standard deviation. IQR: interquartile range. HS: high school. HIS: heavy smoking index. UC: urgent care.
Wilcoxon rank-sum or chi-squared test, as appropriate.
Contraindication checklist and frequency of NRT ineligibility for first product choice by interested parents (N=252)
| 3 (1.9) | 0 | |
| 3 (1.9) | NA | |
| NA | 3 (3.1) | |
| NA | 0 | |
| Heart disease | 3 (1.9) | 1 (1) |
| Arrhythmias | 1 (0.6) | 0 |
| Chest pain/angina | 5 (3.2) | 0 |
| History of heart attack | 4 (2.6) | 0 |
| 1 (0.6) | 0 | |
| 0 | 0 | |
| 1 (0.6) | 0 | |
| 16 (10.3) | 4 (4.1) | |
| 0 | 1 (1) | |
| 0 | 0 | |
| 1 (0.6) | 6 (6.2) | |
NRT: nicotine replacement therapy. NA: not applicable. TMJ: temporomandibular joint dysfunction. HTN: hypertension.
Questions were asked only for the NRT patch.
Questions were asked only for the NRT lozenge.
One participant had hypertension and an adhesion allergy; one participant had hypertension and arrhythmias.